Austin, Texas, Monday 12 December 2016 18.30 GMT
A randomized controlled trial with N = 376 adults with at least moderately severe depression has confirmed that Deprexis is effective in the United States. The trial was led by Professor Christopher Beevers at the University of Texas, Austin. With an impressive effect size of d=0.80, the study provides evidence that Deprexis is at least as effective in the United States as previous Europe-based trials have shown. The study has been accepted for publication in the Journal of Consulting and Clinical Psychology and will be available shortly.